| Serial Number | 98746778 |
| Word Mark | BEONE |
| Filing Date | Thursday, September 12, 2024 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Tuesday, April 28, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 15, 2025 |
| Goods and Services | Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; scientific research in the nature of conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases |
| Goods and Services | Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases |
| Pseudo Mark | BE ONE; BE 1 |
| Goods and Services | Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Friday, November 14, 2025 |
| First Use In Commerce Date | Friday, November 14, 2025 |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 12, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | Tuesday, July 1, 2025 |
| First Use In Commerce Date | Tuesday, July 1, 2025 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, July 1, 2025 |
| First Use In Commerce Date | Tuesday, July 1, 2025 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 12, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Tuesday, July 1, 2025 |
| First Use In Commerce Date | Tuesday, July 1, 2025 |
| Party Name | BEONE MEDICINES I GMBH |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | BASEL 4051 CH |
| Party Name | BeiGene Switzerland GMBH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Basel 4051 CH |
| Party Name | BeiGene Switzerland GMBH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Basel 4051 CH |
| Event Date | Event Description |
| Thursday, September 12, 2024 | NEW APPLICATION ENTERED |
| Monday, September 16, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Monday, September 16, 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Friday, January 24, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 12, 2025 | ASSIGNED TO EXAMINER |
| Monday, March 17, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 17, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 17, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 17, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 17, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 9, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 15, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 15, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 10, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, July 9, 2025 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Thursday, July 10, 2025 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, December 4, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, December 4, 2025 | USE AMENDMENT FILED |
| Tuesday, April 28, 2026 | STATEMENT OF USE PROCESSING COMPLETE |